GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, being > 100-fold selective for IGF-1R/InsR than Akt1/2, Aurora A/B,B-Raf, CDK2, EGFR etc.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | IGF-1R ↓ ↑ | Insulin Receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMS-536924 |
++
IGF-1R, IC50: 100 nM |
+++
Insulin Receptor, IC50: 73 nM |
MEK,FAK | 98% | |||||||||||||||
GSK1904529A |
+++
IGF-1R, IC50: 27 nM |
+++
Insulin Receptor, IC50: 25 nM |
98+% | ||||||||||||||||
Picropodophyllin |
++++
IGF-1R, IC50: 1 nM |
99%+ | |||||||||||||||||
NVP-AEW541 |
++
IGF-1R, IC50: 0.15 μM |
++
Insulin Receptor, IC50: 0.14 μM |
FLT3 | 99%+ | |||||||||||||||
NVP-ADW742 |
+
IGF-1R, IC50: 0.17 μM |
99% | |||||||||||||||||
GSK1838705A |
+++
IGF-1R, IC50: 2 nM |
++++
Insulin Receptor, IC50: 1.6 nM |
ALK | 99% | |||||||||||||||
BMS-754807 |
++++
IGF-1R, IC50: 1.8 nM |
++++
Insulin Receptor, IC50: 1.7 nM |
99%+ | ||||||||||||||||
Linsitinib |
+++
IGF-1R, IC50: 35 nM |
++
Insulin Receptor, IC50: 75 nM |
99%+ | ||||||||||||||||
AG1024 |
+
IGF-1R, IC50: 7 μM |
+
Insulin Receptor, IC50: 57 μM |
98% | ||||||||||||||||
PQ401 |
+
IGF-1R, IC50: <1 μM |
99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | IGF-1R (insulin-like growth factor-1 receptor) plays a key role in transformation, growth and survival of malignant cells, and has been considered as a general and promising target for cancer treatment. GSK1904529A is a selective inhibitor of IGF-IR and IR with IC50 values of 27 and 25nM, respectively. Treatment with GSK1904529A ranging in 0.03-3μM dose-dependently inhibited IGF-1- or insulin-induced autophosphorylation of IGF-1R, as well as the downstream signaling, including phosphorylation of ATK, IRS-1 and ERK. And this inhibition on phosphorylation on IGF-1R and its downstream can be also observed in vivo. In COLO 205, MCF-7, and NCI-H929 cells treated with GSK1904529A ranging in 0.3-10μM for 24h or 48h, dose-dependent increased accumulation in G1 of the cell cycle could be observed. GSK1904529A showed anti-proliferation of cell lines derived from solid and hematologic malignancies, among which multiple myeloma and Ewing’s sarcoma cell lines showed most sensitivity. Oral administration of GSK1904529A at 30mg/kg once daily or twice daily for 21 days significantly inhibited tumor growth inhibition of female nude mice bearing tumor xenografts of NIH-3T3/LISN, COLO 205, HT29 and BxPC3, respectively. As GSK1904529A is also a IR inhibitor, minimal effects on blood glucose levels can be observed in animals treated with a single dose of 30 mg/kg GSK1904529A[1]. |
作用机制 | GSK1904529A is a reversible, ATP-competitive inhibitor.[1] |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
human COLO205 cells | Proliferation assay | 72 h | Antiproliferative activity against human COLO205 cells after 72 hrs by Celltiter assay, IC50=124 nM | 19101143 | |
human LP-1 cells | Proliferation assay | 72 h | Antiproliferative activity against human LP-1 cells after 72 hrs by Celltiter assay, IC50=104 nM | 19101143 | |
human NCI-H929 cells | Proliferation assay | 72 h | Antiproliferative activity against human NCI-H929 cells after 72 hrs by Celltiter assay, IC50=81 nM | 19101143 | |
human SK-ES cells | Proliferation assay | 72 h | Antiproliferative activity against human SK-ES cells after 72 hrs by Celltiter assay, IC50=61 nM | 19101143 | |
Dose | Mice: 30 mg/kg[1] (p.o.) |
Administration | p.o. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.17mL 0.23mL 0.12mL |
5.87mL 1.17mL 0.59mL |
11.74mL 2.35mL 1.17mL |
CAS号 | 1089283-49-7 |
分子式 | C44H47F2N9O5S |
分子量 | 851.963 |
别名 | GSK 4529 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 50 mg/mL(58.69 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |